0000891293-16-000110.txt : 20160226 0000891293-16-000110.hdr.sgml : 20160226 20160226181809 ACCESSION NUMBER: 0000891293-16-000110 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160226 FILED AS OF DATE: 20160226 DATE AS OF CHANGE: 20160226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIANCO JAMES A CENTRAL INDEX KEY: 0001198554 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 161464007 FORMER NAME: FORMER CONFORMED NAME: BLANCO JAMES A DATE OF NAME CHANGE: 20021015 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2016-02-26 0 0000891293 CTI BIOPHARMA CORP ctic 0001198554 BIANCO JAMES A 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 1 1 0 0 President and CEO Common Stock 2016-02-26 4 S 0 10000 0.6294 D 2138302 D The sale was effected pursuant to a Rule 10b5-1 trading plan. By: Louis A. Bianco, Attorney-in-fact For: James A. Bianco 2016-02-26